Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-25-003258

Options or other derivatives

  • Director acquired 12,323 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sukhtian Faisal Ghiath Director 2025-02-04 Grant or award · Stock Option (Right to Buy) +12,323 12,323 D
Loading xslF345X05/form4-02062025_090213.xml…